Results 101 to 110 of about 118,134 (307)
Choroidal neovascularization secondary to Best’s vitelliform macular dystrophy in two siblings of a Malay family [PDF]
, 2014 Best’s vitelliform macular dystrophy complicated with choroidal neovascularization is rare in children. We report three children from a Malay family of five siblings with Best’s vitelliform macular dystrophy, in which two of them subsequently developed ...
Embong, Zunaina +4 more
core
Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome [PDF]
, 2013 OBJECTIVE: To report the visual outcome after 4-year follow-up in a series of highly myopic eyes with choroidal neovascularisation (CNV) treated with antivascular endothelial growth factor (anti-VEGF) drugs.
Arias, L +4 more
core +1 more source
EMBO Molecular Medicine, 2019 This study independently confirms in vivo in the JR5558 mouse model of aberrant retinal angiogenesis, that simultaneous VEGF‐A and ANG‐2 neutralization using a bispecific anti‐VEGF‐A/ANG‐2 antibody reduces vascular leakage, immune reactivity and ...
R. Foxton +4 more
semanticscholar +1 more source
Current Choroidal Neovascularization Treatment [PDF]
Ophthalmologica, 2013 <b><i>Purpose:</i></b> This paper aims to describe the current situation of choroidal neovascularization (CNV) treatment. <b><i>Procedures:</i></b> MEDLINE (2001-2013) was searched for original research studies (phase I, II, III), abstracts and review articles concerning CNV therapy, and other related ...
Ye Panpan, Liu Jian, Xu Wen
openaire +2 more sources
Acta Ophthalmologica, EarlyView.Abstract The aim of this review was to evaluate the comparative efficacy of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy for neovascular AMD. We searched 12 literature databases for randomised clinical trials (RCT) on anti‐VEGF therapy for neovascular AMD and extracted data on: change from baseline to 12 months in best ...
Emilie T. S. Butler +17 more
wiley +1 more source
Pachychoroid neovasculopathy and age-related macular degeneration. [PDF]
, 2015 Pachychoroid neovasculopathy is a recently proposed clinical entity of choroidal neovascularization (CNV). As it often masquerades as neovascular age-related macular degeneration (AMD), it is currently controversial whether pachychoroid neovasculopathy ...
Akagi-Kurashige, Yumiko +11 more
core +1 more source
Acta Ophthalmologica, EarlyView.Abstract Purpose This study evaluates the effectiveness and safety of multiple PDT sessions for cases of persistent and recurrent subretinal fluid (SRF) in chronic central serous chorioretinopathy (CSC). Methods This multicentre, retrospective cohort study included patients aged ≥18 years with chronic CSC who received at least two sessions of PDT at ...
Jennifer M. Chang‐Wolf +7 more
wiley +1 more source
Journal of Ophthalmic & Vision Research, 2013 Purpose: To evaluate the effect of placental growth factor (PlGF) gene knockdown in a murine model of laser-induced choroidal neovascularization. Methods: Choroidal neovascularization was induced in the left eyes of 11 mice by infrared laser.
Ramin Nourinia +5 more
doaj
Kaohsiung Journal of Medical Sciences, 2009 Choroidal neovascularization is a major cause of visual loss in age-related macular degeneration. It is also a potential vision-threatening complication of pathologic myopia, uveitis, traumatic choroidal rupture and, rarely, endophthalmitis.
Shwu-Jiuan Sheu
doaj +1 more source
Retina, 2018 Supplemental Digital Content is Available in the Text. Ranibizumab 0.5 mg administered over 12 months was efficacious and well-tolerated in Asian patients with visual impairment due to myopic choroidal neovascularization.
You-xin Chen +9 more
semanticscholar +1 more source